LONDON (Reuters) - There is little evidence to back the use of a cannabis extract spray made by GW Pharmaceuticals for spasticity in patients with multiple sclerosis, according to a medical journal review published on Thursday.
lost faa medical aircraft leasing ireland coagulation factor vii
No comments:
Post a Comment